A promising new treatment approach for major depressive disorder (MDD) targets the
microbiota-gut-brain (MGB) axis, which is linked to physiological and behavioral functions …

During the past decade, there has been renewed interest in the relationship between brain-
based disorders, the gut microbiota, and the possible beneficial effects of probiotics …

Background: A growing body of research has shown that consumption of probiotics can
improve symptoms associated with mood and anxiety disorders through activity of the gut …

Background: In major depressive disorder (MDD), cognitive dysfunctions strongly contribute
to functional impairments but are barely addressed in current therapies. Novel treatment …

Background: Accumulating evidence has suggested that the bi-directional communication
pathway, the microbiota-gut-brain axis, plays an important role in the pathophysiology of …

Importance The microbiota-gut-brain axis is a promising target for novel treatments for mood
disorders, such as probiotics. However, few clinical trials have been conducted, and further …

Probiotics are currently the subject of intensive research pursuits and also represent a multi-
billion-dollar global industry given their vast potential to improve human health. In addition …

An emerging body of literature demonstrates differences in the gut microbiome (GMB) of
patients with major depressive disorder (MDD) compared to healthy controls (HC), as well …

Depression is one of the most prevalent mental illnesses and is often associated with
various other medical disorders. Since the 1980s, the primary pharmacological treatment …

Background: Recently the gut microbiota has attracted significant interest in psychiatric
research due to the observed bidirectional gut–brain communication. A growing body of …